VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Post by xdmmdx3on Mar 15, 2017 4:25pm

282 Views

Post# 25984442

buying pressure

Okay so the depth message i put out wasn't very clear, sorry about that.

I'll make it simple. Over 1 Million shares on bid from 40 to current bid price. Only 500k on ask up to 50. So double the bid compared to the ask. Also the VWAP (average price stock was bought for today) was 46.3.

This doesn't take a rocket scientist to figure out.

Good luck to all,

x

Bullboard Posts

Debt-free cannabis company set for next stage of growth